vs
Side-by-side financial comparison of CF BANKSHARES INC. (CFBK) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $15.7M, roughly 2.0× CF BANKSHARES INC.). CF BANKSHARES INC. runs the higher net margin — 40.0% vs -32.1%, a 72.2% gap on every dollar of revenue. On growth, CF BANKSHARES INC. posted the faster year-over-year revenue change (12.6% vs -4.5%). CF BANKSHARES INC. produced more free cash flow last quarter ($18.2M vs $25.0K). Over the past eight quarters, CF BANKSHARES INC.'s revenue compounded faster (13.7% CAGR vs -0.1%).
CF Bankshares Inc. is a U.S.-based regional bank holding company operating through its community bank subsidiary. It offers a full suite of personal and commercial banking solutions including deposit products, various loan options, wealth management services and digital banking tools, primarily serving individual consumers and small-to-medium business clients across the U.S. Midwest region.
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
CFBK vs LFCR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $15.7M | $31.1M |
| Net Profit | $5.7M | $-10.0M |
| Gross Margin | — | 25.0% |
| Operating Margin | 43.4% | -9.9% |
| Net Margin | 40.0% | -32.1% |
| Revenue YoY | 12.6% | -4.5% |
| Net Profit YoY | 29.9% | -52.0% |
| EPS (diluted) | $0.88 | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $15.7M | — | ||
| Q3 25 | $15.5M | $31.1M | ||
| Q2 25 | $15.6M | — | ||
| Q1 25 | $14.1M | $35.2M | ||
| Q4 24 | $14.0M | $32.6M | ||
| Q3 24 | $13.1M | $24.7M | ||
| Q2 24 | $12.6M | — | ||
| Q1 24 | $12.2M | $35.7M |
| Q4 25 | $5.7M | — | ||
| Q3 25 | $2.3M | $-10.0M | ||
| Q2 25 | $5.0M | — | ||
| Q1 25 | $4.4M | $-14.8M | ||
| Q4 24 | $4.4M | $-6.6M | ||
| Q3 24 | $4.2M | $-16.2M | ||
| Q2 24 | $1.7M | — | ||
| Q1 24 | $3.1M | $15.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | 25.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 28.0% | ||
| Q4 24 | — | 34.0% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 33.3% |
| Q4 25 | 43.4% | — | ||
| Q3 25 | 17.5% | -9.9% | ||
| Q2 25 | 41.1% | — | ||
| Q1 25 | 39.5% | -25.7% | ||
| Q4 24 | 36.9% | -6.0% | ||
| Q3 24 | 40.4% | -46.9% | ||
| Q2 24 | 15.4% | — | ||
| Q1 24 | 30.9% | -2.5% |
| Q4 25 | 40.0% | — | ||
| Q3 25 | 15.1% | -32.1% | ||
| Q2 25 | 32.3% | — | ||
| Q1 25 | 31.4% | -42.0% | ||
| Q4 24 | 35.2% | -20.2% | ||
| Q3 24 | 32.2% | -65.7% | ||
| Q2 24 | 13.5% | — | ||
| Q1 24 | 25.2% | 43.8% |
| Q4 25 | $0.88 | — | ||
| Q3 25 | $0.36 | $-0.29 | ||
| Q2 25 | $0.77 | — | ||
| Q1 25 | $0.68 | $-0.47 | ||
| Q4 24 | $0.68 | $-0.25 | ||
| Q3 24 | $0.65 | $-0.53 | ||
| Q2 24 | $0.26 | — | ||
| Q1 24 | $0.47 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $259.0M | $18.9M |
| Total DebtLower is stronger | — | $136.0M |
| Stockholders' EquityBook value | $184.4M | $-10.5M |
| Total Assets | $2.1B | $235.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $259.0M | — | ||
| Q3 25 | $272.4M | $18.9M | ||
| Q2 25 | $275.7M | — | ||
| Q1 25 | $241.0M | $5.4M | ||
| Q4 24 | $235.3M | $9.5M | ||
| Q3 24 | $233.5M | — | ||
| Q2 24 | $241.8M | — | ||
| Q1 24 | $236.9M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $136.0M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $124.9M | ||
| Q4 24 | — | $111.3M | ||
| Q3 24 | — | $106.3M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $97.1M |
| Q4 25 | $184.4M | — | ||
| Q3 25 | $179.3M | $-10.5M | ||
| Q2 25 | $177.0M | — | ||
| Q1 25 | $172.7M | $2.2M | ||
| Q4 24 | $168.4M | $15.4M | ||
| Q3 24 | $164.0M | $-3.9M | ||
| Q2 24 | $159.6M | — | ||
| Q1 24 | $158.0M | $17.7M |
| Q4 25 | $2.1B | — | ||
| Q3 25 | $2.1B | $235.2M | ||
| Q2 25 | $2.1B | — | ||
| Q1 25 | $2.1B | $237.7M | ||
| Q4 24 | $2.1B | $255.4M | ||
| Q3 24 | $2.1B | $246.8M | ||
| Q2 24 | $2.0B | — | ||
| Q1 24 | $2.0B | $246.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 56.05× | ||
| Q4 24 | — | 7.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 5.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.7M | $1.8M |
| Free Cash FlowOCF − Capex | $18.2M | $25.0K |
| FCF MarginFCF / Revenue | 115.6% | 0.1% |
| Capex IntensityCapex / Revenue | 3.1% | 5.6% |
| Cash ConversionOCF / Net Profit | 3.26× | — |
| TTM Free Cash FlowTrailing 4 quarters | $33.4M | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.7M | — | ||
| Q3 25 | $5.5M | $1.8M | ||
| Q2 25 | $8.0M | — | ||
| Q1 25 | $2.2M | $1.2M | ||
| Q4 24 | $14.2M | $-6.1M | ||
| Q3 24 | $-1.3M | $-613.0K | ||
| Q2 24 | $4.0M | — | ||
| Q1 24 | $-1.2M | $-1.4M |
| Q4 25 | $18.2M | — | ||
| Q3 25 | $5.2M | $25.0K | ||
| Q2 25 | $7.8M | — | ||
| Q1 25 | $2.2M | $-4.3M | ||
| Q4 24 | $13.9M | $-8.6M | ||
| Q3 24 | $-1.3M | $-4.0M | ||
| Q2 24 | $4.0M | — | ||
| Q1 24 | $-1.2M | $-7.8M |
| Q4 25 | 115.6% | — | ||
| Q3 25 | 33.6% | 0.1% | ||
| Q2 25 | 50.3% | — | ||
| Q1 25 | 15.2% | -12.1% | ||
| Q4 24 | 99.6% | -26.3% | ||
| Q3 24 | -9.9% | -16.3% | ||
| Q2 24 | 31.6% | — | ||
| Q1 24 | -9.5% | -21.8% |
| Q4 25 | 3.1% | — | ||
| Q3 25 | 1.7% | 5.6% | ||
| Q2 25 | 0.7% | — | ||
| Q1 25 | 0.4% | 15.5% | ||
| Q4 24 | 1.9% | 7.5% | ||
| Q3 24 | 0.2% | 13.9% | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.0% | 17.8% |
| Q4 25 | 3.26× | — | ||
| Q3 25 | 2.34× | — | ||
| Q2 25 | 1.58× | — | ||
| Q1 25 | 0.50× | — | ||
| Q4 24 | 3.21× | — | ||
| Q3 24 | -0.30× | — | ||
| Q2 24 | 2.35× | — | ||
| Q1 24 | -0.38× | -0.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CFBK
Segment breakdown not available.
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
